Moderna's Flu Vaccine Gains Favor with FDA Before Advisory Committee Meeting
In recent biotech developments, the FDA seems receptive to Moderna's flu vaccine as UniQure prepares to submit its Huntington's therapy for approval, and Eli Lilly acquires 4E Therapeutics.